GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused

Generates First Half 2026 Revenue Growth of 60% GRAND RAPIDS, Mich., Aug. 6, 2026 — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI),

GRAND RAPIDS, Mich., July 29, 2026 — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on

GRAND RAPIDS, Mich., July 14, 2026 — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on

Refinancing Existing Debt with Significantly Improved Terms Provides Additional Undrawn Working Capital Capacity GRAND RAPIDS, Mich., June 29, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder

GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused